Clinical trial
A Study of the Safety and Effectiveness of Epoetin Alfa on Hemoglobin Levels and…
NCT00216541 · Janssen-Cilag B.V., Industry · Completed
Key facts
| NCT number | NCT00216541 |
|---|---|
| Title | A Study of the Safety and Effectiveness of Epoetin Alfa on Hemoglobin Levels and Blood Transfusions in Cancer Patients Receiving Chemotherapy |
| Official title | Randomised Study to Evaluate the Effect of Early Intervention to Treat Anemia With Epoetin Alfa Versus Standard Use on Hemoglobin Levels and the Incidence of Blood Transfusions in Cancer Patients Receiving Chemotherapy |
| Lead sponsor | Janssen-Cilag B.V., Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Anemia, Neoplasms |
| Intervention type | Drug |
| Interventions | epoetin alfa |
| Enrollment | 110 |
| Start date | Aug 1, 2003 |
| Completion | Sep 1, 2006 |
| First posted | Sep 22, 2005 |
| Last update posted | May 19, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: